| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/17/2008 | US20080090226 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080089901 Hivcon: an hiv immunogen and uses thereof |
| 04/17/2008 | US20080089899 Streptococcus pneumoniae proteins and nucleic |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089892 Fc Region Variants |
| 04/17/2008 | US20080089891 Cancerous disease modifying antibodies |
| 04/17/2008 | US20080089888 Nucleotide sequences coding cancer/testis antigen for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089886 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/17/2008 | US20080089885 Anti-cd20 antibodies and methods of use |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089878 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 04/17/2008 | US20080089862 Serine protease inhibitor for prevention and treatment of cell proliferative, liver and inflammatory disorders |
| 04/17/2008 | US20080089838 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 04/17/2008 | US20080089837 monoclonal antibodies directed to the antigen Platelet derived growth factor-alpha |
| 04/17/2008 | CA2703466A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | CA2683122A1 Therapy targeting cathepsin s |
| 04/17/2008 | CA2683109A1 Combination therapy |
| 04/17/2008 | CA2666249A1 Agent for preventing/treating cancer |
| 04/17/2008 | CA2664903A1 Amino acid sequences that bind to a desired molecule in a conditional manner |
| 04/16/2008 | EP1911768A1 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance |
| 04/16/2008 | EP1911767A2 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 04/16/2008 | EP1911766A1 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 04/16/2008 | EP1911765A2 Prevention, treatment and diagnosis of diseases associated with Beta-Amyloid formation and/or aggregation |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910836A2 Potency assays for antibody drug substance binding to an fc receptor |
| 04/16/2008 | EP1910828A2 Phosphospecific chemokine receptor antibodies |
| 04/16/2008 | EP1910573A2 Methods for reducing viral load in hiv-1-infected patients |
| 04/16/2008 | EP1910550A2 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 04/16/2008 | EP1910420A2 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 04/16/2008 | EP1910419A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/16/2008 | EP1909832A1 Antibody-immune cell ligand fusion protein for cancer therapy |
| 04/16/2008 | EP1909827A2 The modulation of immunity and ceacam1 activity |
| 04/16/2008 | EP1909819A2 Receptor antagonists for treatment of metastatic bone cancer |
| 04/16/2008 | EP1539820B1 Ostertagia vaccine |
| 04/16/2008 | EP1343823B1 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1210604B1 Methods and kits for diagnosing or monitoring a synovial or osteoarticular pathology comprising the use of a specific marker of the synovial tissue degradation |
| 04/16/2008 | EP1169353B1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/16/2008 | EP1100828B1 Methods for making antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | EP0931093B1 Helicobacter pylori live vaccine |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | CN101163720A Rodent pest control |
| 04/16/2008 | CN101163719A TGFβ1特异性抗体 TGFβ1 antibodies |
| 04/16/2008 | CN101163718A Reagents that bind ccx-ckr2 |
| 04/16/2008 | CN101163717A Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 04/16/2008 | CN101163714A Influenza nucleic acids, polypeptides, and uses thereof |
| 04/16/2008 | CN101163502A Antibodies to tgf-beta |
| 04/16/2008 | CN101161676A Saltant APOBEC3G molecule inhibiting HIV reproduction and uses thereof |
| 04/16/2008 | CN101161675A Rice big grain gene and uses thereof |
| 04/16/2008 | CN101161232A Method of producing intravenous injection human hepatitis b immune globulin |
| 04/16/2008 | CN100381820C Method and reagent box for estimating hair growth promoting activity of object to be tested |
| 04/16/2008 | CN100381570C Synovial membrane cell protein |
| 04/16/2008 | CN100381468C Monoclonal antibody ZUB1 of human bone marrow mesenchymal stem cells and application thereof |
| 04/16/2008 | CN100381173C Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 04/16/2008 | CN100381172C Treating prostate cancer with anti-ErbB2 antibodies |
| 04/16/2008 | CA2567394A1 Glycoprotein vi antibodies and methods of use thereof |
| 04/15/2008 | US7358355 Antibodies against human parathyroid hormone related protein |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358352 Tumor necrosis factor; isolating protein from cell culture; use in drug discovery screens compounds that block synthesis |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358350 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358340 PRO19563 antibodies |
| 04/15/2008 | US7358339 PRO polypeptide without the N-terminal signal sequence and/or the initiating methionine is encoded by a nucleotide sequence |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358096 Immobilisation of proteins |
| 04/15/2008 | US7358087 Adjuvant for enhancing immune response to preferential immunogen |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7358042 Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 04/15/2008 | US7358041 Antibodies to magmas and uses thereof |
| 04/15/2008 | US7357929 Placental growth factor as a target for the treatment of osteoporosis |
| 04/15/2008 | US7357927 Death domain containing receptors |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/10/2008 | WO2008042469A2 Knockout mice for different genes and their use for gene characterizatio |
| 04/10/2008 | WO2008042261A2 Anti-anthrax antibody, formulations thereof, and methods of use |
| 04/10/2008 | WO2008042024A2 Neuroactive fragments of app |
| 04/10/2008 | WO2008041012A1 Pharmaceutical composition comprising antibodies against a toxin |
| 04/10/2008 | WO2008040758A1 Peptides with high affinity for the prolactin receptor |
| 04/10/2008 | WO2008040348A2 High througput methods for characterization of antibodies |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040098A1 Immunogenic polypeptides derived from the cleavage loop of precursor hemagglutinin of an influenza virus |
| 04/10/2008 | WO2007120767A3 Agonist erythropoietin receptor antibodies |
| 04/10/2008 | WO2007103523A9 Antioxidant protein, compositions, and methods of use |
| 04/10/2008 | WO2007100833A3 Gpat4 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/10/2008 | WO2006077441A8 Specific binding members for ngf |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085995 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/10/2008 | US20080085993 Fluorescent Compounds |
| 04/10/2008 | US20080085868 Non-infectious nucleic acid construct encoding a recombinant antibody to that agent; injection of a nucleic acid construct, in the form of a plasmid, encoding a virus-neutralising single chain antibody fragment mediates in vivo expression of antibodies; protecting an animal against exposure to a virus |
| 04/10/2008 | US20080085862 Natriuretic peptide conjugate using carrier substance |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085856 insecticidal Cry35 proteins with enhanced properties as compared to wild-type Cry35 proteins. The modifications to these proteins were based in part on analysis of the atomic coordinates and three-dimensional (3D) structure of the 45 kDa 149B1 protein and other proteins in the Cry35 class |